Skip to main content
. 2007 Dec 16;99(3):601–607. doi: 10.1111/j.1349-7006.2007.00705.x

Figure 1.

Figure 1

Antibodies against 146HER2 protein in two representative patients. Left panels: Antibody titers at OD450 absorption in the enzyme‐linked immunosorbent assays at each vaccination cycle. Right panel: IgG subclass analysis. (a) Patient no. 1 who received cholesteryl pullulan (CHP)‐HER2 vaccination alone in the first four cycles. (b) Patient no. 10 who received vaccination of CHP‐HER2 plus granulocyte‐macrophage colony‐stimulating factor.